Evidence map›Paper›PMID 28118831›Full record

ReviewBMC medicine2017

Translational models for vascular cognitive impairment: a review including larger species.

Atticus H Hainsworth, Stuart M Allan, Johannes Boltze, Catriona Cunningham, Chad Farris, Elizabeth Head, Masafumi Ihara, Jeremy D Isaacs, Raj N Kalaria, Saskia A M J Lesnik Oberstein and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in BMC medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 4 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 4 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: Questionnaire and workshop proceedings.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Pooled it
  3. Pooled it
  4. The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Pooled it
  5. Trial
  6. Review
  7. A review of animal models of vascular dementia.Molecular biology reports · 2026
    Review
  8. Article
  9. Current updates on latest basic research of scientific relevance in hypertensive dementia.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. [Prediction of immunotherapy targets for chronic cerebral hypoperfusion by bioinformatics method].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 7 countries.

Atticus H HainsworthClinical Neurosciences (J-0B) Molecular and Clinical Sciences Research Institute, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK. ahainsworth@sgul.ac.uk.
Stuart M AllanFaculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.
Johannes BoltzeDepartment of Translational Medicine and Cell Technology, University of Lübeck, Lübeck, Germany.
Catriona CunninghamFaculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.
Chad FarrisDepartment of Anatomy & Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Elizabeth HeadDepartment of Pharmacology & Nutritional Sciences, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Masafumi IharaDepartment of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center, Osaka, Japan.
Jeremy D IsaacsClinical Neurosciences (J-0B) Molecular and Clinical Sciences Research Institute, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK.
Raj N KalariaInstitute of Neuroscience, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, UK.
Saskia A M J Lesnik ObersteinDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
Mark B MossDepartment of Anatomy & Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Björn NitzscheFraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Gary A RosenbergDepartment of Neurology, Health Sciences Center, University of New Mexico, Albuquerque, NM, USA.
Julie W RuttenDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
Melita Salkovic-PetrisicDepartment of Pharmacology, Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Aron M TroenInstitute of Biochemistry Food and Nutrition Science, Hebrew University of Jerusalem, Rehovot, Israel.
Boston University · USLeiden University Medical Center · NLSt George's, University of London · GBUniversity of Manchester · GBHebrew University of Jerusalem · ILLeipzig University · DEMassachusetts General Hospital · USNational Cerebral and Cardiovascular Center · JPNewcastle University · GBUniversity of Kentucky · USUniversity of New Mexico · USUniversity of Zagreb · HR

Funding

Alzheimer's Society 151British Heart Foundation PG/13/8/29989Medical Research Council G0400074Medical Research Council G0502157Medical Research Council G0900652Medical Research Council G1100540Medical Research Council MR/L023784/1Medical Research Council MR/L023784/2National Centre for the Replacement, Refinement and Reduction of Animals in Research G0800701/1
6 · The paper itself

Abstract

backgroundDisease models are useful for prospective studies of pathology, identification of molecular and cellular mechanisms, pre-clinical testing of interventions, and validation of clinical biomarkers. Here, we review animal models relevant to vascular cognitive impairment (VCI). A synopsis of each model was initially presented by expert practitioners. Synopses were refined by the authors, and subsequently by the scientific committee of a recent conference (International Conference on Vascular Dementia 2015). Only peer-reviewed sources were cited.

methodsWe included models that mimic VCI-related brain lesions (white matter hypoperfusion injury, focal ischaemia, cerebral amyloid angiopathy) or reproduce VCI risk factors (old age, hypertension, hyperhomocysteinemia, high-salt/high-fat diet) or reproduce genetic causes of VCI (CADASIL-causing Notch3 mutations).

conclusionsWe concluded that (1) translational models may reflect a VCI-relevant pathological process, while not fully replicating a human disease spectrum; (2) rodent models of VCI are limited by paucity of white matter; and (3) further translational models, and improved cognitive testing instruments, are required.

Indexed as

Disease Models, AnimalAnimalsBrainDementia, VascularRisk FactorsExperimental modelsIn vivo modelsTranslational modelsVascular cognitive impairmentVascular dementiaVCID

Identifiers

PMID28118831
PMCPMC5264492
OpenAlexW2580859812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.